Balance sheet of Astec Lifesciences is strong.
But short term working capital might become an issue for this company.

Yes, The debt of Astec Lifesciences is increasing.
Latest debt of Astec Lifesciences is ₹498 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹489 Crs.

No, profit is decreasing.
The profit of Astec Lifesciences is -₹103.56 Crs for TTM, -₹46.93 Crs for Mar 2024 and ₹25.56 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Astec Lifesciences latest dividend payout ratio is 11.5% and 3yr average dividend payout ratio is 7.39%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Capital Work in Progress, Accounts Receivable